SCHEMBL5265319

SCHEMBL5265319

CC[N]c1ccc(C(F)(F)F)cc1C(N)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.42
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 2/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CFTR P13569 1/20 0.40
CASP1 P29466 1/20 0.39
JAK2 O60674 3/20 0.38
JAK1 P23458 2/20 0.38
TYK2 P29597 2/20 0.38
PDE2A O00408 1/20 0.38
NOTUM Q6P988 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
KMT2A Q03164 1/20 0.37
DPP7 Q9UHL4 2/20 0.37
NOS3 P29474 2/20 0.37
NOS1 P29475 2/20 0.37
NOS2 P35228 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5261896 0.80 KEAP1 (0.40) CES2JAK2MAPK8
SCHEMBL24720949 0.79 JAK2 (0.50) CES2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL5264746 0.78 ALDH1A1 (0.39) ALDH1A1KDM4EHPGDSMN1; SMN2KMT2A
SCHEMBL5264419 0.78 KDM4E (0.41) ALDH1A1KDM4EHPGDHSD17B10CASP1
SCHEMBL688068 0.76 MAP2K2 (0.37) ALDH1A1HPGDSMN1; SMN2DPP7CYP1A2
SCHEMBL5262040 0.74 KDM4E (0.48) ALDH1A1KDM4EHPGDCASP1SMN1; SMN2
SCHEMBL5323409 0.74 CES2 (0.50) CES2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL5265322 0.73 LIPC (0.50) CES2ALDH1A1KDM4EHPGDHSD17B10
Methylamine SCHEMBL3227067 0.72 CES2 (0.68) CES2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL2856986 0.72 CES2 (0.72) CES2ALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740551-A1 HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF AS AN MMP-13 INHIBITOR Takeda Pharmaceutical Company Limited (JP) 2007-01-10 EP disclosed
WO-2005105760-A1 HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF AS AN MMP-13 INHIBITOR TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-11-10 WO disclosed